Michael Nagel - 30 Jun 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBPQ)

Role
Director
Signature
/s/ Daniel Clark, attorney-in-fact
Issuer symbol
KRBPQ
Transactions as of
30 Jun 2022
Net transactions value
$0
Form type
4
Filing time
05 Jul 2022, 16:02:14 UTC
Next filing
06 Oct 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Stock Option (Right to Buy) Award $0 +183,600 +3479% $0.000000 188,878 30 Jun 2022 Common Stock 183,600 $0.4300 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock options vest according to the following schedule: (a) 50% of the options vest on June 30, 2022, (b) 25% of the options vest on September 30, 2022, and (c) the remaining 25% of the options vest on December 31, 2022.

Remarks:

Exhibit 24.1 - Power of Attorney